Bayer and Kumquat Biosciences ink $1.3 billion deal to develop cancer inhibitor
HQ Team August 13, 2025: Bayer and Kumquat Biosciences, a clinical-stage biotech, announced an exclusive global license and collaboration agreement worth $1.3 billion.
Uncategorized
Health
Research
Mid-frontal brain folds key to schizophrenia: Zurich study finds
HQ Team February 27, 2025: The uniformity of brain folding in the mid-frontal area suggests a developmental trait common to people with schizophrenia,.